IND
Biophytis gains IND approval from FDA for obesity study
July 11, 2024Medical Communications Biophytis, IND, Obesity, clinical trial, obesity
Biophytis has announced that it has received investigational new drug (IND) approval from the US Food and Drug Administration (FDA) …
Full-Life Technologies’ IND application for prostate cancer cleared by FDA
May 30, 2024Medical Communications Full-Life Technologies, IND, Oncology, prostate cancer
Full-Life Technologies has announced that the US Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) Application …
FDA clears Aruna Bio’s IND for AB126 to enter clinical trials
January 17, 2024Research and Development Aruna Bio, FDA, IND, Neurology, clinical trials
Aruna Bio has announced that the US Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application …
Artiva Biotherapeutics announces FDA clearance of IND for AlloNK and Rituximab combo
August 17, 2023Research and Development FDA, IND, Immunology, lupus nephritis, pharma
On 16 August 2023, the US Food and Drug Administration (FDA) officially cleared Artiva Biotherapeutics’ Investigational New Drug (IND) application …
Skyline Therapeutics receives FDA clearance of IND for candidate for neovascular age-related macular degeneration
July 5, 2023Research and Development FDA, IND, Opthalmology, Skyline Therapeutics, neovascular age-related macular degeneration
Skyline Therapeutics has announced that the US Food and Drug Administration (FDA) has cleared its Investigational New Drug (IND) application …
Latest content
FibroFind appoints Lee Borthwick as CEO
July 21, 2026
